Teleflex Hits 52-Week Low On Plan To Split Into Two Companies, Reports Mixed Q4 Earnings
1. Teleflex will separate into two independent firms by mid-2026. 2. RemainCo focuses on vascular, interventional, and surgical businesses with $2.1B revenue. 3. Teleflex acquires Biotronik's vascular intervention business for €760 million. 4. RemainCo anticipates over 6% revenue growth and double-digit EPS growth post-separation. 5. Teleflex's fourth-quarter sales missed consensus, and CFO will retire in April.